Mese: Aprile 2025

Claris Ventures Announces First Closing of Claris Biotech II

Claris Ventures Announces First Closing of Claris Biotech II Turin – April 23, 2025 – Claris Ventures today announced the first closing […]

Ricerca per:

Haptena launches with €3 million seed financing from Claris Ventures to develop innovative treatments for KRAS-driven cancers
Claris Ventures Announces First Closing of Claris Biotech II
Claris Ventures and Exor Ventures Team Up for the Development of Innovative Drugs in Italy
Claris Ventures and Evotec Forge Powerful Partnership to Fast-Track Portfolio Programs Into Clinical Advancement
Newly launched TCR company ALKemist Bio announces a €6.9M Investment Round to develop first-in-class TCR Cell Therapy for ALK-Positive Tumors

Piazza San Carlo 206, Torino, Italy

+39 (0) 11 3325889

VAT: 12116290011

PEC: clarisventures.pec [at] maildoc.it